Hormone-related risk factors for breast cancer in women under age 50 years by estrogen and progesterone receptor status: results from a case-control and a case-case comparison
It has been suggested that hormonal risk factors act predominantly on estrogen receptor and progesterone receptor (ER/PR)-positive breast cancers. However, the data have been inconsistent, especially in younger women.
Methods
We evaluated the impact of age at menarche, pregnancy history, duration of breastfeeding, body mass index, combined oral contraceptive use, and alcohol consumption on breast cancer risk by ER/PR status in 1,725 population-based case patients and 440 control subjects aged 20 to 49 years identified within neighborhoods of case patients. We used multivariable unconditional logistic regression methods to conduct case-control comparisons overall as well as by
breast cancer hormone-related risk, ER PR receptor status cancer, oral contraceptive breast cancer young women, reproductive factors cancer subtype, age at menarche breast cancer, breastfeeding cancer protection, BMI breast cancer risk, population-based case-control cancer, estrogen receptor-positive cancer, progesterone receptor breast cancer
PMID 16846528 16846528 DOI 10.1186/bcr1514 10.1186/bcr1514
Cite this article
Ma, H., Bernstein, L., Ross, R. K., & Ursin, G. (2006). Hormone-related risk factors for breast cancer in women under age 50 years by estrogen and progesterone receptor status: results from a case-control and a case-case comparison. *Breast cancer research : BCR*, *8*(4), R39. https://doi.org/10.1186/bcr1514
Ma H, Bernstein L, Ross RK, Ursin G. Hormone-related risk factors for breast cancer in women under age 50 years by estrogen and progesterone receptor status: results from a case-control and a case-case comparison. Breast Cancer Res. 2006;8(4):R39. doi:10.1186/bcr1514
Ma, H., et al. "Hormone-related risk factors for breast cancer in women under age 50 years by estrogen and progesterone receptor status: results from a case-control and a case-case comparison." *Breast cancer research : BCR*, vol. 8, no. 4, 2006, pp. R39.
Bethea TN et al., 2015
Open Access
Breast cancer research : BCR
Introduction: Recent oral contraceptive (OC) use has been consistently associated with increased risk of breast cancer, but evidence on specific breast cancer subtypes is sparse.
Methods: We investig...
Hunter DJ et al., 2010Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology
Background: Previous studies convincingly showed an increase in risk of breast cancer associated with current or recent use of oral contraceptives from the 1960s to 1980s. The relation of contemporary...
Dolle JM et al., 2009Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology
Little is known about the etiologic profile of triple-negative breast cancer (negative for estrogen receptor/progesterone receptor/human epidermal growth factor), a breast cancer subtype associated wi...
A tubo-ovarian abscess (TOA) is a complication of pelvic inflammatory disease (PID) resulting from an ascending infection of the upper genital tract. It is characterized by an inflammatory mass involv...